Report Materials
EXECUTIVE SUMMARY:
The objectives of this audit were to determine whether awardees: recorded, summarized, and reported bioterrorism program transactions by focus area in accordance with their cooperative agreements; established procedures to monitor subrecipient expenditures; and had unobligated fund balances as of August 30, 2003. We determined that of the 17 audited awardees: fourteen recorded, summarized, and reported bioterrorism program funds by focus area; six had developed adequate procedures to monitor subrecipient expenditures; and fifteen had unobligated balances of Federal bioterrorism funds as of August 30, 2003 totaling approximately $65 million, or 15 percent of the $428 million awarded. We recommended that CDC: (1) continue to emphasize the requirement to account for funds by focus area; (2) identify awardees that have not accounted for their funds in accordance with the cooperative agreements and ensure that they revise their accounting procedures; (3) provide guidance to awardees on monitoring subrecipient expenditures and measuring subrecipient performance, including emphasizing the need for awardees to make site visits to directly review subrecipients' expenditures and assess subrecipients' progress in improving bioterrorism preparedness; and (4) identify the reasons for large unobligated balances and assist the awardees in overcoming barriers to a more timely use of funds. In response, the CDC officials agreed with the findings and recommendations.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.